1. Home
  2. MRSN vs JRSH Comparison

MRSN vs JRSH Comparison

Compare MRSN & JRSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • JRSH
  • Stock Information
  • Founded
  • MRSN 2001
  • JRSH 2016
  • Country
  • MRSN United States
  • JRSH United States
  • Employees
  • MRSN N/A
  • JRSH N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • JRSH Apparel
  • Sector
  • MRSN Health Care
  • JRSH Consumer Discretionary
  • Exchange
  • MRSN Nasdaq
  • JRSH Nasdaq
  • Market Cap
  • MRSN 47.1M
  • JRSH 43.1M
  • IPO Year
  • MRSN 2017
  • JRSH 2018
  • Fundamental
  • Price
  • MRSN $27.87
  • JRSH $3.26
  • Analyst Decision
  • MRSN Buy
  • JRSH Strong Buy
  • Analyst Count
  • MRSN 5
  • JRSH 1
  • Target Price
  • MRSN $30.38
  • JRSH $4.00
  • AVG Volume (30 Days)
  • MRSN 211.4K
  • JRSH 126.0K
  • Earning Date
  • MRSN 11-14-2025
  • JRSH 11-12-2025
  • Dividend Yield
  • MRSN N/A
  • JRSH 6.21%
  • EPS Growth
  • MRSN N/A
  • JRSH N/A
  • EPS
  • MRSN N/A
  • JRSH 0.07
  • Revenue
  • MRSN $33,180,000.00
  • JRSH $144,505,598.00
  • Revenue This Year
  • MRSN N/A
  • JRSH $7.62
  • Revenue Next Year
  • MRSN N/A
  • JRSH $8.35
  • P/E Ratio
  • MRSN N/A
  • JRSH $49.08
  • Revenue Growth
  • MRSN N/A
  • JRSH 17.11
  • 52 Week Low
  • MRSN $5.21
  • JRSH $2.81
  • 52 Week High
  • MRSN $70.73
  • JRSH $4.17
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 89.87
  • JRSH 45.71
  • Support Level
  • MRSN $7.59
  • JRSH $3.18
  • Resistance Level
  • MRSN $28.07
  • JRSH $3.36
  • Average True Range (ATR)
  • MRSN 0.69
  • JRSH 0.10
  • MACD
  • MRSN 1.80
  • JRSH -0.01
  • Stochastic Oscillator
  • MRSN 99.51
  • JRSH 28.33

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About JRSH Jerash Holdings (US) Inc.

Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.

Share on Social Networks: